Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd-Rüdiger Balda
Michael Hertl

Showing results (11-20 of 245) with videos related to

Pageof 25
Sort By:
Journal of Clinical Epidemiology|July 13, 2004
The prevalence of contact allergy differed between population-based and clinic-based dataWolfgang Uter, Alika Ludwig, Bernd-Rüdiger Balda, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2006
Autoimmune bullous disordersRüdiger Eming, Michael Hertl,
Der Internist|January 12, 2019
[Recognize rare diseases on the skin]Bruno Gualtieri, Michael Hertl
Autoimmunity|November 15, 2006
Immunoadsorption in pemphigusRüdiger Eming, Michael Hertl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2019
NachrufMichael Hertl, Alexander Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 27, 2011
Autoimmune bullous skin diseases. Part 2: diagnosis and therapyAndrea Kneisel, Michael Hertl
The British Journal of Dermatology|December 10, 2024
Targeting type 2 inflammation in bullous pemphigoid: dupilumab as a game changer opens new avenuesLuca Borradori, Michael Hertl
The Journal of Investigative Dermatology|February 16, 2016
Clinical and Molecular Characterization of Autoimmune Bullous DiseasesMichael Hertl, Detlef Zillikens
JAMA Dermatology|June 28, 2013
Underrecognition of the heterogeneous clinical spectrum of bullous pemphigoidMichael Hertl, Thomas Schmidt
Autoimmunity Reviews|September 11, 2003
T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skinMichael Hertl, Christian Veldman
Pageof 25

Showing results (11-20 of 245) with videos related to

Sort By:
Pageof 25
Journal of Clinical Epidemiology|July 13, 2004
The prevalence of contact allergy differed between population-based and clinic-based dataWolfgang Uter, Alika Ludwig, Bernd-Rüdiger Balda, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2006
Autoimmune bullous disordersRüdiger Eming, Michael Hertl,
Der Internist|January 12, 2019
[Recognize rare diseases on the skin]Bruno Gualtieri, Michael Hertl
Autoimmunity|November 15, 2006
Immunoadsorption in pemphigusRüdiger Eming, Michael Hertl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2019
NachrufMichael Hertl, Alexander Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 27, 2011
Autoimmune bullous skin diseases. Part 2: diagnosis and therapyAndrea Kneisel, Michael Hertl
The British Journal of Dermatology|December 10, 2024
Targeting type 2 inflammation in bullous pemphigoid: dupilumab as a game changer opens new avenuesLuca Borradori, Michael Hertl
The Journal of Investigative Dermatology|February 16, 2016
Clinical and Molecular Characterization of Autoimmune Bullous DiseasesMichael Hertl, Detlef Zillikens
JAMA Dermatology|June 28, 2013
Underrecognition of the heterogeneous clinical spectrum of bullous pemphigoidMichael Hertl, Thomas Schmidt
Autoimmunity Reviews|September 11, 2003
T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skinMichael Hertl, Christian Veldman
Pageof 25